148 related articles for article (PubMed ID: 27639374)
21. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
[TBL] [Abstract][Full Text] [Related]
22. Human leukemia and lymphoma cell lines as models and resources.
MacLeod RA; Nagel S; Scherr M; Schneider B; Dirks WG; Uphoff CC; Quentmeier H; Drexler HG
Curr Med Chem; 2008; 15(4):339-59. PubMed ID: 18288989
[TBL] [Abstract][Full Text] [Related]
23. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
[TBL] [Abstract][Full Text] [Related]
24. In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma.
Suter SE; Chein MB; von Messling V; Yip B; Cattaneo R; Vernau W; Madewell BR; London CA
Clin Cancer Res; 2005 Feb; 11(4):1579-87. PubMed ID: 15746063
[TBL] [Abstract][Full Text] [Related]
25. A cultured approach to canine urothelial carcinoma: molecular characterization of five cell lines.
Shapiro SG; Knapp DW; Breen M
Canine Genet Epidemiol; 2015; 2():15. PubMed ID: 26401343
[TBL] [Abstract][Full Text] [Related]
26. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
27. Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations.
Rücker FG; Sander S; Döhner K; Döhner H; Pollack JR; Bullinger L
Leukemia; 2006 Jun; 20(6):994-1001. PubMed ID: 16721385
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells.
Nadeau MÈ; Rico C; Tsoi M; Vivancos M; Filimon S; Paquet M; Boerboom D
BMC Cancer; 2015 Jun; 15():479. PubMed ID: 26104798
[TBL] [Abstract][Full Text] [Related]
29. Comparison of cellular and tissue transcriptional profiles in canine mammary tumor.
Pawlowski KM; Krol M; Majewska A; Badowska-Kozakiewicz A; Mol JA; Malicka E; Motyl T
J Physiol Pharmacol; 2009 May; 60 Suppl 1():85-94. PubMed ID: 19609017
[TBL] [Abstract][Full Text] [Related]
30. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
31. A novel canine lymphoma cell line: a translational and comparative model for lymphoma research.
Kisseberth WC; Nadella MV; Breen M; Thomas R; Duke SE; Murahari S; Kosarek CE; Vernau W; Avery AC; Burkhard MJ; Rosol TJ
Leuk Res; 2007 Dec; 31(12):1709-20. PubMed ID: 17532464
[TBL] [Abstract][Full Text] [Related]
32. DNA microarrays in lymphoid malignancies.
Rosenwald A
Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
[TBL] [Abstract][Full Text] [Related]
33. The effect of common antineoplastic agents on induction of apoptosis in canine lymphoma and leukemia cell lines.
Pawlak A; Rapak A; Zbyryt I; Obmińska-Mrukowicz B
In Vivo; 2014; 28(5):843-50. PubMed ID: 25189898
[TBL] [Abstract][Full Text] [Related]
34. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
[TBL] [Abstract][Full Text] [Related]
35. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
Nasr MR; Rosenthal N; Syrbu S
Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic characterization of canine lymphoproliferative disorders.
Ruslander DA; Gebhard DH; Tompkins MB; Grindem CB; Page RL
In Vivo; 1997; 11(2):169-72. PubMed ID: 9179611
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.
Andersson A; Edén P; Lindgren D; Nilsson J; Lassen C; Heldrup J; Fontes M; Borg A; Mitelman F; Johansson B; Höglund M; Fioretos T
Leukemia; 2005 Jun; 19(6):1042-50. PubMed ID: 15843827
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
